Cargando…
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates among all cancer types. Its delayed diagnosis precludes curative resection, thus most of the current therapies against PDAC are based on chemo- and radiotherapy. Unfortunately, these strategies are insufficient to improve...
Autores principales: | Quiñonero, Francisco, Mesas, Cristina, Doello, Kevin, Cabeza, Laura, Perazzoli, Gloria, Jimenez-Luna, Cristina, Rama, Ana Rosa, Melguizo, Consolación, Prados, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936232/ https://www.ncbi.nlm.nih.gov/pubmed/31908888 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0252 |
Ejemplares similares
-
The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
por: Doello, Kevin, et al.
Publicado: (2021) -
Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021)
por: Mesas, Cristina, et al.
Publicado: (2022) -
Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
por: Chico, Maria Angeles, et al.
Publicado: (2023) -
In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review
por: Luque, Cristina, et al.
Publicado: (2022) -
Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review
por: Cepero, Ana, et al.
Publicado: (2022)